Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Immunology | Infections and Infectious Diseases | Family Medicine
Disease Category: Staphylococcal Infections
Location: United States, NY
Clinical Trial Details
Research Study Summary
(MRSA) Methicillin-Resistant Staphylococcus Aureus
Winthrop University Hospital Clinical Trials Center in conjunction with The Winthrop Internal Medicine Association is conducting a clinical research study for patients who have been hospitalized for a skin and skin structure infection. This research study will look at effectiveness of two antibiotics.This study will compare the effectiveness of two FDA approved antibiotics used for the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA).
During the study, eligible participants will receive study drug and all study procedures that are not part of the standard of care at no cost.
Compensation may be provided for time and travel.
Patient Inclusion Criteria:
To be eligible for the study, you must;
- Be at least 18 years of age
- Be hospitalized (for less than 24 hours)with a skin and skin structure infection of a complicated nature (major cutaneous absess or wound infection) that requires IV antibiotics treatment for 3 to 14 days of hospitalization management.
- Infection suspected or documented to be caused by MRSA
To Learn more
Both Male and Female
Date Last Changed:
July 19, 2013
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.